Table 4.
Discharge medications (n = 104)
| Medication | Count | Discharge dosage (mg/d) | Count (combinations categorized) | Breakthrough SVT |
|---|---|---|---|---|
| Amiodarone | 5 (3.8%) | 17 (10-22) | 2 (1.9%) | 2/2 (100%) |
| Digoxin | 14 (10.5%) | 0.03 (0.015-0.07) | 4 (3.8%) | 1/4 (25.0%) |
| Flecainide | 24 (18.0%) | 18 (9-40) | 11 (10.6%) | 3/11 (27.3%) |
| Propranolol | 74 (55.6%) | 9 (0.9-24.96) | 56 (53.8%) | 13/56 (23.2%) |
| Sotalol | 11 (8.3%) | 22.5 (3.6-45) | 5 (4.8%) | 2/5 (40.0%) |
| Propafenone | 2 (1.5%) | 75 (60-90) | n/a | n/a |
| None | 3 (2.3%) | n/a | 3 (2.9%) | 3/3 (100%) |
| Combination | n/a | n/a | 23 (22.1%) | 2/23 (8.7%) |
Medications prescribed at discharge and the rate of breakthrough SVT events throughout follow-up for each discharge medication.
n/a, not available; SVT, supraventricular tachycardia.